Details for Patent: 7,718,640

Which drugs does patent 7,718,640 protect, and when does it expire?

Patent 7,718,640 protects AVEED and is included in one NDA.

This patent has fifty-two patent family members in thirty-eight countries.

Summary for Patent: 7,718,640

Patent landscape, scope, and claims:

Title:	Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
Abstract:	The present invention relates to pharmaceutical compositions, formulated for injectable administration, which comprises a testosterone ester, in particularly testosterone undecanoate, in a vehicle comprising castor oil and a co-solvent. Upon injecting the compositions according to a particular administration scheme, reliable levels of testosterone in serum in the normal physiological range is achieved for a long period. This allows for the use of the compositions in hormone replacement therapy and male contraception without concomitant monitoring of testosterone levels in serum by a physician.
Inventor(s):	Hubler; Doris (Jena, DE), Fricke; Sabine (Jena, DE), Ingwersen; Jan-Peter (Berlin, DE), Kuhnz; Wilhelm (Berlin, DE)
Assignee:	Bayer-Schering Pharma AG (Berlin, DE)
Application Number:	10/798,780
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,718,640
Patent Claim Types: see list of patent claims	Composition;

Drugs Protected by US Patent 7,718,640

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Endo Operations	AVEED	testosterone undecanoate	INJECTABLE;INTRAMUSCULAR	022219-001	Mar 5, 2014		RX	Yes	Yes			Y

International Family Members for US Patent 7,718,640

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	043603
Austria	336251
Australia	2004218893
Brazil	PI0400214